- £3.96bn
- £3.44bn
- $3.85bn
- 27
- 64
- 63
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Other Revenue | |||||
Total Revenue | 2,912 | 3,000 | 3,023 | 3,813 | 3,846 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,859 | 3,268 | 2,833 | 3,539 | 3,221 |
Operating Profit | 53.1 | -268 | 190 | 275 | 625 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 53.1 | -268 | 191 | 276 | 625 |
Provision for Income Taxes | |||||
Net Income After Taxes | 48.9 | -293 | 190 | 254 | 711 |
Net Income Before Extraordinary Items | |||||
Net Income | 48.9 | -293 | 190 | 254 | 711 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 48.9 | -294 | 190 | 254 | 711 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.174 | 0.047 | 0.533 | 0.727 | 2.06 |
Dividends per Share |